Cover Image
市場調查報告書

美國的抗菌塑膠市場: 家電,個人保養品,包裝,汽車,建築,醫療,及其他用途所採用的抗菌塑膠的產業分析,市場規模,市場佔有率,成長度,市場趨勢,未來預測

U.S. Antimicrobial Plastics Market for Electronic & Consumer Appliances, Personal Care, Packaging, Automotive, Building & Construction, Healthcare and Other Applications - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

出版商 Transparency Market Research 商品編碼 309699
出版日期 內容資訊 英文 76 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的抗菌塑膠市場: 家電,個人保養品,包裝,汽車,建築,醫療,及其他用途所採用的抗菌塑膠的產業分析,市場規模,市場佔有率,成長度,市場趨勢,未來預測 U.S. Antimicrobial Plastics Market for Electronic & Consumer Appliances, Personal Care, Packaging, Automotive, Building & Construction, Healthcare and Other Applications - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
出版日期: 2014年07月08日 內容資訊: 英文 76 Pages
簡介

抗菌塑膠廣泛使用於醫療及汽車用、建築用、包裝用、家電、電子產品等領域,此外由於消費者對健康及清潔的意識提升,預測這個市場將更形擴大。

本報告詳查美國的抗菌塑膠市場,提供市場現狀,主要的推動市場成長要素,阻礙因素,市場機會等,再詳細檢驗、分析市場動態,估算目前市場規模及市場預測。再分析美國市場上的主要企業包含其產品、服務及企業策略、彙整詳細的企業簡介,加上市場佔有率等市場競爭狀況。

第1章 序言

  • 關於本報告
  • 市場分類
  • 調查手法

第2章 摘要整理

  • 美國的抗菌塑膠市場 - 2013∼2020年
  • 美國的抗菌塑膠: 市場概述 (2013年與2020年)

第3章 抗菌塑膠 - 產業分析

  • 序論
  • 價值鏈分析
  • 推動市場成長要素
    • 醫療器具需求的增加擴大了抗菌塑膠市場
      • 美國的醫療器具市場 - 2013∼2020年
    • 高院內感染率的發生推動了抗菌塑膠需求的增加
      • 美國各感染疾病類型院內感染明細 (2011年)
    • 抗菌塑膠包裝需求的增加
      • 美國的塑膠包裝市場 - 2013∼2020年
  • 阻礙市場成長要素
    • 原料價格不穩定影響市場成長
      • 銀國際價格 - 2009∼2014年
  • 市場機會
    • 透過產品技術創新開拓市場成長機會
  • 美國的法律規章方案
  • 波特的五力分析
  • 市場魅力分析
  • 各企業市場佔有率分析

第4章 抗菌塑膠市場 - 各用途分析

  • 美國的抗菌塑膠市場: 用途概要
    • 美國的抗菌塑膠銷售量的各用途市場佔有率 - 2013年與2020年
  • 美國的各用途抗菌塑膠市場
    • 電子產品及家電品
      • 美國的電子產品及家電品抗菌塑膠市場 - 2013∼2020年
    • 個人保健產品
      • 美國的個人保養品用抗菌塑膠市場 - 2013∼2020年
    • 包裝用品
      • 美國的包裝用品抗菌塑膠市場 - 2013∼2020年
    • 汽車
      • 美國的汽車用抗菌塑膠市場 - 2013∼2020年
    • 建築
      • 美國的大樓及建築產業的抗菌塑膠市場 - 2013∼2020年
    • 醫療
      • 美國的醫療用品抗菌塑膠市場 - 2013∼2020年
    • 其他
      • 美國的其他的用途抗菌塑膠市場 - 2013∼2020年

第5章 主要企業簡介

  • AkzoNobel N.V.
    • 公司概要
    • 產品系列
    • 財務狀況
    • 商務策略
    • SWOT分析
    • 最近的企業發展
  • BASF SE
  • Bayer AG
  • Diamond Vogel
  • E. I. du Pont de Nemours and Company
  • 石塚硝子株式會社
  • Lonza Group AG
  • Momentive Performance Materials Inc.
  • 株式會社shinanenzeomikku
  • Sciessent LLC
  • Sherwin-Williams
  • Teknor Apex
  • The Dow Chemical Company

附圖

附表

目錄

Antimicrobial plastics are molded polymers infused with antimicrobials to inhibit the growth of various harmful microorganisms such as fungi and bacteria. Antimicrobial plastics are used in various industries such as healthcare, automotives, building & construction, electronics, packaging and consumer goods. Additionally, they are used in niche applications such as pipes, plastic water storage containers, waste bins and lids. Rising awareness among consumers regarding good health and cleanliness is expected to be one of the primary factors driving the growth of the antimicrobial plastics market.

Antimicrobial plastics are increasingly used in packaging and electronic appliances as these products are highly susceptible to germs. This may result in transfer of infections. Additionally, growth in electronics, healthcare and packaging industries is anticipated to boost demand for antimicrobial plastics. Higher willingness of consumers to increase expenditure on products with antimicrobial properties is estimated to contribute significantly to the growth of the market.

The report on U.S.antimicrobial plastics market report forecasts and analyzes the antimicrobial plastics market on a regional level. The forecast demand on the global level is based on volume (tons) and revenue (USD million) for the period ranging from 2014 to 2020. The study on U.S. antimicrobial plastics market outlines drivers and restraints of the polyester market and their impact on market growth during the mentioned time period. Additionally, the study includes opportunities available for the market on the regional and level and their effect during the said forecast period.

All plastics infused with antimicrobials have been classified as antimicrobial plastics under the scope of this study. Personal care includes packaging of personal care products. Packaging of healthcare products has been classified under the packaging segment. Packaging typically includes foods, beverages and pharmaceuticals. In other words, the segment includes all types of packaging, except for personal care products.

We have conducted a detailed analysis of the value chain in order to help understand the antimicrobial plastics market better. Furthermore, Porter's five forces model provides a better understanding of the intensity of competition in the market. The study comprises a market attractiveness analysis, wherein key applications are benchmarked based on their market size, growth rate and general attractiveness.

For the research report, we conducted in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by an extensive secondary research. We reviewed key players' product literature, annual reports, press releases and relevant documents for competitive analysis and market understanding. Secondary research also includes a search of recent trade, technical writing, internet sources, and statistical data from government websites, trade associations and agencies. This has proven to be the most reliable, effective and successful approach for obtaining precise market data, capturing industry participants' insights and recognizing business opportunities.

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the U.S. market. Key players profiled in the report include AkzoNobel N.V, BASF SE, Bayer AG, Bayer AG, E. I. du Pont de Nemours and Company, Lonza Group AG, Momentive Performance Materials Inc, Sinanen Zeomic Co Ltd, Sciessent LLC, Sherwin-Williams and Teknor Apex. Company profiles include attributes such as company overview, financial overview, business strategy, SWOT analysis and recent developments.

The study provides a decisive view of the antimicrobial plastics market by segmenting the market based on applications. All the applications have been analyzed based on present and future trends and the market is estimated from 2014 to 2020. The regional segmentation includes the current and forecast demand for U.S. This segmentation includes demand for individual applications in the particular region. For the purpose of this study, the antimicrobial plastics market has been segmented based on applications. Application segments have been analyzed and forecasted based on current trends at the regional level for the period between 2014 and 2020. The market has been segmented as below:

U.S. Antimicrobial Plastics Market - Application Segment Analysis

  • Electronics & consumer appliances
  • Personal care
  • Packaging
  • Automotive
  • Building & construction
  • Healthcare
  • Others (Includes sportswear, waste bins, etc.)

Table of Contents

Chapter 1 - Preface

  • 1.1. Report description
  • 1.2. Market segmentation
    • 1.2.1. U.S. antimicrobial plastics market segmentation
  • 1.3. Research methodology
    • 1.3.1. Assumptions

Chapter 2 - Executive Summary

  • 2.1. U.S. antimicrobial plastics market, 2013 - 2020 (Tons) (USD Million)
  • 2.2. U.S. antimicrobial plastics: Market snapshot (2013 and 2020)

Chapter 3 - Antimicrobial Plastics - Industry Analysis

  • 3.1. Introduction
  • 3.2. Value chain analysis
  • 3.3. Market drivers
    • 3.3.1. Growing demand for medical devices to augment market for antimicrobial plastics
      • 3.3.1.1. U.S. medical devices market, 2013 - 2020 (USD Billion)
    • 3.3.2. High rate of hospital-acquired infections to fuel demand for antimicrobial plastics
      • 3.3.2.1. U.S. hospital-acquired infection (HAIs) breakdown by types of infections, 2011 (%)
    • 3.3.3. Increasing demand for antimicrobial plastics in packaging
      • 3.3.3.1. U.S. plastic packaging market, 2013 - 2020 (USD Billion)
  • 3.4. Market restraints
    • 3.4.1. Volatility in prices of raw materials to impact market growth
      • 3.4.1.1. Global silver prices, 2009 - 2014 (USD/kg)
  • 3.5. Market opportunities
    • 3.5.1. Product innovation to open opportunities for market growth
  • 3.6. U.S. regulatory scenario
  • 3.7. Porter's five forces analysis
    • 3.7.1. Bargaining power of suppliers
    • 3.7.2. Bargaining power of buyers
    • 3.7.3. Threat of new entrants
    • 3.7.4. Threat of substitutes
    • 3.7.5. Degree of competition
  • 3.8. Market attractiveness analysis
  • 3.9. Company market share analysis

Chapter 4 - Antimicrobial Plastics Market - Application Analysis

  • 4.1. U.S. antimicrobial plastics market: application overview
    • 4.1.1. U.S. antimicrobial plastics market volume share, by application, 2013 and 2020
  • 4.2. U.S antimicrobial plastics market, by application
    • 4.2.1. Electronics & consumer appliances
      • 4.2.1.1. U.S. antimicrobial plastics market for electronics & consumer appliances, 2013 - 2020 (Tons) (USD Million)
    • 4.2.2. Personal care
      • 4.2.2.1. U.S antimicrobial plastics market for personal care, 2013 - 2020 (Tons) (USD Million)
    • 4.2.3. Packaging
      • 4.2.3.1. U.S. antimicrobial plastics market for packaging, 2013 - 2020 (Tons) (USD Million)
    • 4.2.4 Automotives
      • 4.2.4.1 U.S. antimicrobial plastics market for automotives, 2013 - 2020 (Tons) (USD Million)
    • 4.2.5. Building & construction
      • 4.2.5.1. U.S. antimicrobial plastics market for building & construction, 2013 - 2020 (Tons) (USD Million)
    • 4.2.6. Healthcare
      • 4.2.6.1. U.S. antimicrobial plastics market for healthcare, 2013 - 2020 (Tons) (USD Million)
    • 4.2.7. Others
      • 4.2.7.1. U.S. antimicrobial plastics market for other applications, 2013 - 2020 (Tons) (USD Million)

Chapter 5 - Company Profiles

  • 5.1. AkzoNobel N.V.
    • 5.1.1. Company overview
    • 5.1.2. Product portfolio
    • 5.1.3. Financial overview
    • 5.1.4. Business strategy
    • 5.1.5. SWOT analysis
    • 5.1.6. Recent developments
  • 5.2. BASF SE
    • 5.2.1. Company overview
    • 5.2.2. Product portfolio
    • 5.2.3. Financial overview
    • 5.2.4. Business strategy
    • 5.2.5. SWOT analysis
    • 5.2.6. Recent developments
  • 5.3. Bayer AG
    • 5.3.1. Company overview
    • 5.3.2. Product portfolio
    • 5.3.3. Financial overview
    • 5.3.4. Business strategy
    • 5.3.5. SWOT analysis
    • 5.3.6. Recent developments
  • 5.4. Diamond Vogel
    • 5.4.1. Company overview
    • 5.4.2. Product portfolio
    • 5.4.3. Business strategy
    • 5.4.4. SWOT analysis
    • 5.4.5. Recent developments
  • 5.5. E. I. du Pont de Nemours and Company
    • 5.5.1. Company overview
    • 5.5.2. Product portfolio
    • 5.5.3. Financial overview
    • 5.5.4. Business strategy
    • 5.5.5. SWOT analysis
    • 5.5.6. Recent developments
  • 5.6. Ishizuka Glass Co. Ltd.
    • 5.6.1. Company overview
    • 5.6.2. Product portfolio
    • 5.6.3. Financial overview
    • 5.6.4. Business strategy
    • 5.6.5. SWOT analysis
    • 5.6.6. Recent developments
  • 5.7. Lonza Group AG
    • 5.7.1. Company overview
    • 5.7.2. Product portfolio
    • 5.7.3. Financial overview
    • 5.7.4. Business strategy
    • 5.7.5. SWOT analysis
    • 5.7.6. Recent developments
  • 5.8. Momentive Performance Materials Inc.
    • 5.8.1. Company overview
    • 5.8.2. Product portfolio
    • 5.8.3. Financial overview
    • 5.8.4. SWOT analysis
    • 5.8.5. Recent developments
  • 5.9. Sinanen Zeomic Co Ltd
    • 5.9.1. Company overview
    • 5.9.2. Product portfolio
    • 5.9.3. Business strategy
    • 5.9.4. SWOT analysis
    • 5.9.5. Recent developments
  • 5.10. Sciessent LLC
    • 5.10.1. Company overview
    • 5.10.2. Product portfolio
    • 5.10.3. Business strategy
    • 5.10.4. SWOT analysis
    • 5.10.5. Recent developments
  • 5.11. Sherwin-Williams
    • 5.11.1. Company overview
    • 5.11.2. Product portfolio
    • 5.11.3. Financial overview
    • 5.11.4. Business strategy
    • 5.11.5. SWOT analysis
    • 5.11.6. Recent developments
  • 5.12. Teknor Apex
    • 5.12.1. Company overview
    • 5.12.2. Product portfolio
    • 5.12.3. Business strategy
    • 5.12.4. SWOT analysis
  • 5.13. The Dow Chemical Company
    • 5.13.1. Company overview
    • 5.13.2. Product portfolio
    • 5.13.3. Financial overview
    • 5.13.4. Business strategy
    • 5.13.5. SWOT analysis

List of Figures

  • FIG. 1: U.S. antimicrobial plastics market segmentation
  • FIG. 2: U.S. antimicrobial plastics market, 2013 - 2020 (Tons) (USD Million)
  • FIG. 3: U.S. antimicrobial plastics market: Value chain analysis
  • FIG. 4: U.S. medical devices market, 2013 - 2020 (USD Billion)
  • FIG. 5: U.S. hospital acquired infection (HAIs) breakdown by types of infections, 2011 (%)
  • FIG. 6: U.S. plastic packaging market, 2013 - 2020 (USD Billion)
  • FIG. 7: Global silver prices, 2009 - 2014 (USD/kg)
  • FIG. 8: Porter's five forces analysis
  • FIG. 9: U.S. antimicrobial plastics: Market attractiveness analysis
  • FIG. 10: U.S. antimicrobial plastics: Company market share analysis (2013)
  • FIG. 11: U.S. antimicrobial plastics market volume share, by application, 2013 and 2020
  • FIG. 12: U.S. antimicrobial plastics market for electronics & consumer appliances, 2013 -2020 (Tons) (USD Million)
  • FIG. 13: U.S. Antimicrobial Plastics Market for Personal Care, 2013 - 2020 (Tons) (USD Million)
  • FIG. 14: U.S. antimicrobial plastics for packaging, 2013 - 2020 (Tons) (USD Million)
  • FIG. 15: U.S. antimicrobial plastics for automotives, 2013 - 2020 (Tons) (USD Million)
  • FIG. 16: U.S. antimicrobial plastics for building & construction, 2013 - 2020 (Tons) (USD Million)
  • FIG. 17: U.S. antimicrobial plastics for healthcare, 2013 - 2020 (Tons) (USD Million)
  • FIG. 18: U.S. antimicrobial plastics for other applications, 2013 - 2020 (Tons) (USD Million)

List of Tables

  • TABLE 1: Antimicrobial plastics: U.S. snapshot
  • TABLE 2: Drivers for antimicrobial plastics market: Impact analysis
  • TABLE 3: Restraints for antimicrobial plastics market: Impact analysis
Back to Top